John Harman
Overview
Explore the profile of John Harman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamuntavicius G, Prat A, Paquet T, Bastas O, Aty H, Sun Q, et al.
J Cheminform
. 2024 Nov;
16(1):127.
PMID: 39543721
Background: Target identification and hit identification can be transformed through the application of biomedical knowledge analysis, AI-driven virtual screening and robotic cloud lab systems. However there are few prospective studies...
2.
Delextrat A, Bateman J, Ross C, Harman J, Davis L, Vanrenterghem J, et al.
J Strength Cond Res
. 2019 Aug;
34(2):396-405.
PMID: 31425454
Delextrat, A, Bateman, J, Ross, C, Harman, J, Davis, L, Vanrenterghem, J, and Cohen, DD. Changes in torque-angle profiles of the hamstrings and hamstrings-to-quadriceps ratio after two hamstring strengthening exercise...
3.
Harman J, Govender S, Simpson J, Benjamin B
Plast Reconstr Surg
. 2018 Dec;
143(1):49-52.
PMID: 30589775
In New Zealand, oncoplastic surgery is common, but partial breast reconstruction presents challenges for radiation therapy targeting. Tissue rearrangement creates ambiguity when targeting the tumor bed, with resultant overestimation of...
4.
Chen C, Tucci F, Jiang W, Tran J, Fleck B, Hoare S, et al.
Bioorg Med Chem
. 2008 Apr;
16(10):5606-18.
PMID: 18417348
A series of 2-piperazine-alpha-isopropylbenzylamine derivatives were synthesized and characterized as melanocortin-4 receptor (MC4R) antagonists. Attaching an amino acid to benzylamines 7 significantly increased their binding affinity, and the resulting compounds...
5.
Tran J, Jiang W, Tucci F, Fleck B, Wen J, Sai Y, et al.
J Med Chem
. 2007 Nov;
50(25):6356-66.
PMID: 17994683
Benzylamine and pyridinemethylamine derivatives were synthesized and characterized as potent and selective antagonists of the melanocortin-4 receptor (MC4R). These compounds were also profiled in rodents for their pharmacokinetic properties. Two...
6.
Govender S, Harman J, Ramsaroop R
ANZ J Surg
. 2003 Jul;
73(7):552-3.
PMID: 12864839
No abstract available.
7.
McIntyre H, Blue J, Harman J
N Z Med J
. 2002 Oct;
115(1157):U45.
PMID: 12362194
Aim: To demonstrate a seasonal variation in the detection of breast cancer in women diagnosed at St Marks Breast Centre, Auckland. Methods: Data on women diagnosed with breast cancer at...
8.
Harman J, Blue J, Gregory M, Weight S
Breast J
. 2002 Aug;
8(5):325-6.
PMID: 12199767
No abstract available.
9.
Benjamin B, Ziginskas D, Harman J, Meakin T
Psychooncology
. 2002 Jul;
11(3):244-8.
PMID: 12112485
Aims: To determine whether specific pulsed electrostatic fields, or electrotrichogenesis (ETG), could potentially prevent or reduce hair loss in patients undergoing adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy for breast...
10.
Greenberg D, McIntyre H, Ramsaroop R, Arthur J, Harman J
Breast J
. 2002 Feb;
8(1):55-7.
PMID: 11856165
Aggressive fibromatosis is a rare, locally aggressive disease. It constitutes 0.3% of all solid tumors, but the tumor is rarely seen in the breast, particularly without pectoral muscle and fascial...